No state in America has been spared the ravages of the opioid epidemic, but new research reveals the striking differences in how different states have tried to address the problem.
The study by Advocates for Opioid Recovery showed that some states have enthusiastically embraced the use of buprenorphine in treating opioid dependence. Others have almost completely resisted its use.
In Vermont, for instance, more than two-thirds of all prescriptions for buprenorphine were paid for by Medicaid. In Mississippi, only 4 percent of such prescriptions were funded by Medicaid.
Recommended For You
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
